SCHEMBL25823394

SCHEMBL25823394

c1ccc(CN(c2ccccc2)c2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)cc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.50
TSHR P16473 2/20 0.47
HDAC1 Q13547 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
KCNA3 P22001 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
CYP2C19 P33261 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CNR2 P34972 2/20 0.43
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23435088 1.00 NR3C2 (0.50) NR3C2TSHRHDAC1HDAC8HDAC6
SCHEMBL22384546 0.96 HDAC1 (0.49) NR3C2TSHRHDAC1HDAC8HDAC6
SCHEMBL1702260 0.94 NR3C2 (0.54) NR3C2TSHRHDAC1HDAC8HDAC6
SCHEMBL21126417 0.92 TAAR1 (0.53) NR3C2TSHRHDAC1HDAC8HDAC6
SCHEMBL20961703 0.90 HDAC1 (0.53) NR3C2TSHRHDAC1HDAC8HDAC6
SCHEMBL20859794 0.90 HDAC1 (0.53) NR3C2TSHRHDAC1HDAC8HDAC6
SCHEMBL66561 0.90 TAAR1 (0.54) NR3C2TSHRHDAC1HDAC8HDAC6
SCHEMBL14373647 0.90 TAAR1 (0.54) NR3C2TSHRHDAC1HDAC8HDAC6
SCHEMBL23992546 0.88 TAAR1 (0.57) NR3C2TSHRHDAC1HDAC8HDAC6
SCHEMBL9215743 0.87 TAAR1 (0.56) NR3C2TSHRHDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225202-A1 CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225202-A1 CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CRY2, PER2 NR3C2 1211/4885TSHR 3721/4885HDAC1 1458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.